HUMMINGBIRD BIOSCIENCE HOLDINGS PTE LTD has a total of 36 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are HUMMINGBIRD BIOSCIENCE PTE LTD, SHANGHAI NOVAMAB BIOPHARMACEUTICALS CO LTD and ORUM THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 10 | |
#2 | United States | 5 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Republic of Korea | 3 | |
#7 | Singapore | 3 | |
#8 | Taiwan | 3 | |
#9 | United Kingdom | 2 | |
#10 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Ingram Piers | 34 |
#2 | Paszkiewicz Konrad | 32 |
#3 | Thakkar Dipti | 31 |
#4 | Boyd-Kirkup Jerome Douglas | 30 |
#5 | Wu Zhihao | 30 |
#6 | Guan Siyu | 28 |
#7 | Sancenon Vicente | 24 |
#8 | Brauer Peter | 10 |
#9 | Boyd Kirkup Jerome Douglas | 3 |
#10 | Wu Zhi-Hao | 2 |
Publication | Filing date | Title |
---|---|---|
GB202017319D0 | BCMA and CD47 antigen-binding molecules | |
GB201913079D0 | Treatment and prevention of cancer using her3 antigen-binding molecules | |
AU2018358004A1 | CD47 antigen-binding molecules | |
WO2019086574A1 | Cd47 and cd33 antigen-binding molecules | |
WO2019185163A1 | Vista antigen-binding molecules | |
WO2019185164A1 | Her3 antigen-binding molecules |